Compare NPCE & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NPCE | DFP |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 514.3M | 429.0M |
| IPO Year | 2021 | N/A |
| Metric | NPCE | DFP |
|---|---|---|
| Price | $15.75 | $21.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $18.14 | N/A |
| AVG Volume (30 Days) | ★ 243.9K | 56.2K |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.73% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $94,864,000.00 | N/A |
| Revenue This Year | $25.30 | N/A |
| Revenue Next Year | $0.42 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $7.56 | $15.45 |
| 52 Week High | $18.98 | $19.31 |
| Indicator | NPCE | DFP |
|---|---|---|
| Relative Strength Index (RSI) | 44.45 | 57.01 |
| Support Level | $16.20 | $21.22 |
| Resistance Level | $17.44 | $21.39 |
| Average True Range (ATR) | 0.85 | 0.13 |
| MACD | -0.16 | 0.02 |
| Stochastic Oscillator | 2.03 | 57.14 |
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.